Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes

被引:18
作者
Riner, Andrea N. [1 ]
Underwood, Patrick W. [1 ]
Yang, Kai [2 ]
Herremans, Kelly M. [1 ]
Cameron, Miles E. [1 ,3 ]
Chamala, Srikar [4 ]
Qiu, Peihua [2 ]
George, Thomas J. [5 ]
Permuth, Jennifer B. [6 ,7 ]
Merchant, Nipun B. [8 ]
Trevino, Jose G. [1 ]
机构
[1] Univ Florida, Dept Surg, Coll Med, 1600 SW Archer Rd,POB 100109, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Biostat, Coll Med, Gainesville, FL 32610 USA
[3] Univ Florida, Dept Phys Therapy, Coll Med, Gainesville, FL 32610 USA
[4] Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Gainesville, FL 32610 USA
[5] Univ Florida, Dept Med, Coll Med, Div Hematol & Oncol, Gainesville, FL 32610 USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL USA
[8] Univ Miami, Coll Med, Dept Surg, Miami, FL USA
基金
美国国家卫生研究院;
关键词
pancreatic ductal adenocarcinoma; survival; RACIAL DISPARITIES; CANCER; SURVIVAL;
D O I
10.1002/cam4.3042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Disparities exist among patients with pancreatic ductal adenocarcinoma (PDAC). Non-White race is regarded as a negative predictor of expected treatment and overall survival. Data suggest that Academic Research Programs (ARP) provide better outcomes for minorities, but ethnic/minority outcomes are underreported. We hypothesize that outcomes among racially/ethnically diverse PDAC patients may be influenced by treatment facility. Methods The National Cancer Database was used to identify 170,327 patients diagnosed with PDAC between 2004 and 2015. Cox proportional-hazard regression was used to compare survival between race/ethnic groups across facilities. Results In unadjusted models, compared to non-Hispanic Whites (NHW), non-Hispanic Blacks (NHB) had the worst overall survival (HR = 1.05, 95%CI: 1.03-1.06, P < .001) and Hispanics had the best overall survival (HR = 0.92, 95%CI: 0.90-0.94, P < .001). After controlling for socioeconomic and clinical covariates, NHB (HR = 0.95, 95%CI: 0.93-0.96, P < .001) had better overall survival compared to NHW, and Hispanics continued to have the best comparative outcomes (HR = 0.84, 95%CI: 0.82-0.86, P < .001). Among Hispanics, Dominicans and South/Central Americans lived the longest, at 10.25 and 9.82 months, respectively. The improved survival in Hispanics was most pronounced at ARP (HR = 0.80, 95%CI: 0.77-0.84, P < .001) and Integrated Network Cancer Programs (HR = 0.78, 95%CI: 0.73-0.84, P < .001). NHB had improved survival over NHW at Comprehensive Community Care Programs (HR = 0.96, 95%CI: 0.93-0.98, P = .002) and ARP (HR = 0.96, 95%CI: 0.94-0.98, P = .001), which was influenced by income, education, and surgical resection. Conclusion Survival was improved at ARP for all populations. Hispanics had the best comparative overall survival. NHB had improved overall survival at higher volume centers, but this was dependent upon income, education, and surgical resection.
引用
收藏
页码:4069 / 4082
页数:14
相关论文
共 21 条
[1]  
[Anonymous], 2015, MODERN IMMIGRATION W
[2]   Racial/ethnic differences in physician distrust in the United States [J].
Armstrong, Katrina ;
Ravenell, Karima L. ;
McMurphy, Suzanne ;
Putt, Mary .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2007, 97 (07) :1283-1289
[3]   National failure to operate on early stage pancreatic cancer [J].
Bilimoria, Karl Y. ;
Bentrem, David J. ;
Ko, Clifford Y. ;
Stewart, Andrew K. ;
Winchester, David P. ;
Talamonti, Mark S. .
ANNALS OF SURGERY, 2007, 246 (02) :173-180
[4]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[5]   Influence of facility type on survival outcomes after pancreatectomy for pancreatic adenocarcinoma [J].
Chu, Quyen D. ;
Zhou, Meijiao ;
Peddi, Prakash ;
Medeiros, Kaelen L. ;
Zibari, Gazi B. ;
Shokouh-Amiri, Hosein ;
Wu, Xiao-Cheng .
HPB, 2017, 19 (12) :1046-1057
[6]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[7]   Long-Term Survivors of Pancreatic Cancer: A California Population-Based Study [J].
Kardosh, Adel ;
Lichtensztajn, Daphne Y. ;
Gubens, Matthew A. ;
Kunz, Pamela L. ;
Fisher, George A. ;
Clarke, Christina A. .
PANCREAS, 2018, 47 (08) :958-966
[8]   Racial differences in pancreatic cancer: Comparison of survival and histologic types of pancreatic carcinoma in Asians, Blacks, and Whites in the United States [J].
Longnecker, DS ;
Karagas, MR ;
Tosteson, TD ;
Mott, LA .
PANCREAS, 2000, 21 (04) :338-343
[9]   Health Disparities Impact Expected Treatment of Pancreatic Ductal Adenocarcinoma Nationally [J].
Lutfi, Waseem ;
Zenati, Mazen S. ;
Zureikat, Amer H. ;
Zeh, Herbert J. ;
Hogg, Melissa E. .
ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (07) :1860-1867
[10]   Healthcare disparities in outcomes of patients with resectable pancreatic cancer [J].
Moaven, Omeed ;
Richman, Joshua S. ;
Reddy, Sushanth ;
Wang, Thomas ;
Heslin, Martin J. ;
Contreras, Carlo M. .
AMERICAN JOURNAL OF SURGERY, 2019, 217 (04) :725-731